Winald R Gerritsen

5PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 08, 2022
Health-related quality of life, psychological distress, and fatigue in metastatic castration-resistant prostate cancer patients treated with radium-223 therapy.

Maarten J van der Doelen, Irma M Oving, Dirk N J Wyndaele

|Jul 13, 2021
Impact of DNA damage repair defects on response to PSMA radioligand therapy in metastatic castration-resistant prostate cancer.

Bastiaan M Privé, Peter H J Slootbeek, Babette I Laarhuis

|Mar 22, 2021
The effects of new life-prolonging drugs for metastatic castration-resistant prostate cancer (mCRPC) patients in a real-world population.

H M Westgeest, M C P Kuppen, A J M van den Eertwegh

|Mar 09, 2021
Early alkaline phosphatase dynamics as biomarker of survival in metastatic castration-resistant prostate cancer patients treated with radium-223.

Maarten J van der Doelen, Agnes Stockhaus, Yuanjun Ma

|Feb 01, 2018
A clinically relevant decrease in abiraterone exposure associated with carbamazepine use in a patient with castration-resistant metastatic prostate cancer.

Guillemette E Benoist, Maarten J van der Doelen, Rob Ter Heine

Pageof 1